ANDA 70162, held by Barr. Tolazamide.
As of Nov 16, 2026, ANDA 70162 (Tolazamide), held by Barr, was first approved by FDA on Jan 14, 1986, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 14, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolazamide100MG ยท tablet;oral | Tolazamide | Discontinued |
| Aug 21, 1991 | Supplement 12Labeling | Approved | None posted |
| Sep 19, 1989 | Supplement 11Labeling | Approved | None posted |
| Jan 14, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters